[A15-25] Belatacept - Benefit assessment according to § 35a Social Code Book V (dossier assessment)
Last updated 15.10.2015
Project no.:
A15-25
Commission:
Commission awarded on 02.07.2015 by the Federal Joint Committee (G-BA).
Report type:
Dossier assessment
Status:
Commission completed
Department/Division:
Drug Assessment
Topic:
Immune system and infections
Note:
After completion of the assessment by IQWiG the Federal Joint Committee (G-BA) conducts a commenting procedure. This may provide supplementary information and as a result lead to a modified benefit assessment. Further information and the decision on the early benefit assessment can be found on the relevant page of the G-BA website.
| Project no. | Title | Status |
|---|---|---|
| A15-51 | Belatacept - Addendum to Commission A15-25 | Commission completed |
| A12-03 | Belatacept -Benefit assessment according to § 35a Social Code Book V (dossier assessment) | Commission completed |
Federal Joint Committee (G-BA)
2016-01-07 A G-BA decision was published.